CHCLPharmaceuticals
Cian Healthcare Ltd — Profit & Loss Statement
₹73.03
+0.00%
Cian Healthcare Ltd Profit & Loss Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | -12300.00 | 0.03 Cr | -57338.89 | -0.06 Cr |
| Tax Rate For Calcs | 0.30 | 0.30 | 0.08 | 0.30 |
| Normalized EBITDA | 11.31 Cr | 13.00 Cr | 4.51 Cr | 11.89 Cr |
| Total Unusual Items | -41000.00 | 0.11 Cr | -0.07 Cr | -0.21 Cr |
| Total Unusual Items Excluding Goodwill | -41000.00 | 0.11 Cr | -0.07 Cr | -0.21 Cr |
| Net Income From Continuing Operation Net Minority Interest | 0.25 Cr | 2.03 Cr | -5.53 Cr | 0.05 Cr |
| Reconciled Depreciation | 5.47 Cr | 5.43 Cr | 4.24 Cr | 3.45 Cr |
| Reconciled Cost Of Revenue | 30.75 Cr | 33.44 Cr | 47.91 Cr | 40.47 Cr |
| EBITDA | 11.31 Cr | 13.11 Cr | 4.44 Cr | 11.68 Cr |
| EBIT | 5.84 Cr | 7.68 Cr | 0.16 Cr | 8.23 Cr |
| Net Interest Income | -5.79 Cr | -5.69 Cr | -6.39 Cr | -7.72 Cr |
| Interest Expense | 5.79 Cr | 5.69 Cr | 6.16 Cr | 7.54 Cr |
| Normalized Income | 0.26 Cr | 1.95 Cr | -5.47 Cr | 0.20 Cr |
| Net Income From Continuing And Discontinued Operation | 0.25 Cr | 2.03 Cr | -5.53 Cr | 0.05 Cr |
| Total Expenses | 56.30 Cr | 61.64 Cr | 77.59 Cr | 64.99 Cr |
| Diluted NI Availto Com Stockholders | 0.25 Cr | 2.03 Cr | -5.53 Cr | 0.05 Cr |
| Net Income Common Stockholders | 0.25 Cr | 2.03 Cr | -5.53 Cr | 0.05 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 0.25 Cr | 2.03 Cr | -5.53 Cr | 0.05 Cr |
| Net Income Including Noncontrolling Interests | 0.25 Cr | 2.03 Cr | -5.53 Cr | 0.05 Cr |
| Net Income Continuous Operations | 0.25 Cr | 2.03 Cr | -5.53 Cr | 0.05 Cr |
| Tax Provision | -0.20 Cr | -0.04 Cr | -0.47 Cr | 0.63 Cr |
| Pretax Income | 0.05 Cr | 1.99 Cr | -6.00 Cr | 0.69 Cr |
| Other Non Operating Income Expenses | 0.44 Cr | 0.62 Cr | 0.01 Cr | 16000.00 |
| Special Income Charges | -41000.00 | 0.11 Cr | -0.07 Cr | -0.21 Cr |
| Net Non Operating Interest Income Expense | -5.79 Cr | -5.69 Cr | -6.39 Cr | -7.72 Cr |
| Interest Expense Non Operating | 5.79 Cr | 5.69 Cr | 6.16 Cr | 7.54 Cr |
| Operating Income | 5.40 Cr | 6.95 Cr | 0.28 Cr | 8.74 Cr |
| Operating Expense | 25.55 Cr | 28.20 Cr | 29.68 Cr | 24.52 Cr |
| Other Operating Expenses | 11.52 Cr | 13.36 Cr | 8.31 Cr | 7.59 Cr |
| Depreciation And Amortization In Income Statement | 5.47 Cr | 5.43 Cr | 4.27 Cr | 3.45 Cr |
| Depreciation Income Statement | 5.47 Cr | 5.43 Cr | 4.27 Cr | 3.45 Cr |
| Gross Profit | 30.95 Cr | 35.15 Cr | 29.96 Cr | 33.26 Cr |
| Cost Of Revenue | 30.75 Cr | 33.44 Cr | 47.91 Cr | 40.47 Cr |
| Total Revenue | 61.70 Cr | 68.59 Cr | 77.87 Cr | 73.73 Cr |
| Operating Revenue | 61.70 Cr | 68.59 Cr | 77.87 Cr | 73.73 Cr |
| Interest Income | — | 0.14 Cr | 0.16 Cr | 0.19 Cr |
| Rent Expense Supplemental | — | 0.50 Cr | 0.41 Cr | 0.33 Cr |
| Diluted Average Shares | — | 2.51 Cr | 2.50 Cr | 2.65 Cr |
| Basic Average Shares | — | 2.51 Cr | 2.50 Cr | 2.65 Cr |
| Diluted EPS | — | 0.81 | -2.21 | 0.02 |
| Basic EPS | — | 0.81 | -2.21 | 0.02 |
| Other Special Charges | — | -0.11 Cr | 0.07 Cr | 0.21 Cr |
| Total Other Finance Cost | — | 0.52 Cr | 0.39 Cr | 0.37 Cr |
| Interest Income Non Operating | — | 0.14 Cr | 0.16 Cr | 0.19 Cr |
| Research And Development | — | 0.00 | 0.00 | — |
| Selling General And Administration | — | 5.59 Cr | 6.96 Cr | 6.17 Cr |
| Selling And Marketing Expense | — | 0.23 Cr | 0.18 Cr | 0.27 Cr |
| General And Administrative Expense | — | 5.37 Cr | 6.78 Cr | 5.90 Cr |
| Rent And Landing Fees | — | 0.50 Cr | 0.41 Cr | 0.33 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Cian Healthcare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.